Kathiresan Sekar — SEC Form 4 filings
SEC reporting owner CIK 1864112. 9 Form 4 filings on record with FilingPulse; latest filed 2025-09-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-16 to 2025-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 9,822 shares, $40,761 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 9,822 shares @ $4.15 ($40,761) in Verve Therapeutics, Inc., filed 2025-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) | Chief Executive Officer, Director | 6 | — | 1 leg · 9,822 sh · $40,761 | 24 |
| Relay Therapeutics, Inc. (RLAY) | Director | 2 | — | — | 2 |
| Maze Therapeutics, Inc. (MAZE) | Director | 1 | — | — | 1 |
Form 4 filings — Kathiresan Sekar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-09-24 | 4 | Maze Therapeutics, Inc. (MAZE) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2025-07-28 | 4 | Verve Therapeutics, Inc. (VERV) | Code (U): 348,431 · Code (U): 110,997 · Code (U): 240,997 · Disposition to issuer (D): 488,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · +7 more | EDGAR |
| 2025-06-06 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 136,681 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Verve Therapeutics, Inc. (VERV) | Option exercise (M): 33,000 · Sale (S): 9,822 @ $4.15 · Option exercise (M): 33,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 488,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Verve Therapeutics, Inc. (VERV) | Gift (G): 30,000 @ $0 · Gift (G): 30,000 @ $0 | EDGAR |
| 2024-07-02 | 4 | Verve Therapeutics, Inc. (VERV) | Option exercise (M): 30,000 @ $2.87 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 102,225 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 526,000 (derivative) @ $0 · Grant/award (A): 132,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1864112 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →